Clincosm LogoSign in Get a demo

metastatic breast cancer

Showing NaN - NaN of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in United States (Enzalutamide, Mifepristone, TPC)

Recruiting
  • Metastatic Breast Cancer
  • Birmingham, Alabama
  • +5 more
Oct 19, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Orange City, Florida
  • +27 more
Jul 19, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Boston (Cessation of anti-HER2 treatment)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Cessation of anti-HER2 treatment
  • Boston, Massachusetts
  • +1 more
Feb 9, 2023

Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Phoenix, Arizona
  • +36 more
Jan 27, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

Recruiting
  • Metastatic Breast Cancer
  • Anchorage, Alaska
  • +58 more
Jan 6, 2023

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Metastatic Breast Cancer
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)

Recruiting
  • Breast Cancer
  • +5 more
  • MRI
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 9, 2022

Metastatic Breast Cancer Trial in Japan, United States (Patritumab Deruxtecan)

Active, not recruiting
  • Metastatic Breast Cancer
  • Patritumab Deruxtecan
  • Newnan, Georgia
  • +25 more
Dec 5, 2022

Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab

Recruiting
  • Invasive Breast Cancer
  • +3 more
  • Atlanta, Georgia
  • +7 more
Nov 14, 2022

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Palbociclib in Real World Practice

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • non-interventional
  • Alabaster, Alabama
  • +304 more
Oct 10, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer Trial in Worldwide (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
Apr 20, 2022

Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Recurrent Breast Cancer
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • Miami, Florida
  • +21 more
Mar 18, 2022

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
Has Results
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Metastatic Breast Cancer, Chemo-induced Alopecia Trial in Boston (Paxman Scalp Cooling System, Eribulin, Sacituzumab govitecan)

Recruiting
  • Metastatic Breast Cancer
  • Chemotherapy-induced Alopecia
  • Paxman Scalp Cooling System
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

Breast Cancer, Metastatic Breast Cancer Trial in Boston (Prolonged Nightly Fasting, Exercise)

Recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • Prolonged Nightly Fasting
  • Exercise
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 5, 2022

Metastatic Breast Cancer Trial in United States (Pertuzumab, Trastuzumab)

Completed
Has Results
  • Metastatic Breast Cancer
  • Tucson, Arizona
  • +15 more
Dec 3, 2021

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Metastatic Breast Cancer Trial in Worldwide (Placebo, Veliparib, Carboplatin)

Completed
Has Results
  • Metastatic Breast Cancer
  • Placebo
  • +4 more
  • Birmingham, Alabama
  • +119 more
Sep 27, 2021

Metastatic Breast Cancer, Leptomeningeal Disease Trial in United States (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Metastatic Breast Cancer
  • Leptomeningeal Disease
  • Birmingham, Alabama
  • +8 more
Oct 12, 2021